Results 61 to 70 of about 43,933 (287)

Marijuana: A systems-based primer of adverse effects associated with use and an overview of its therapeutic utility

open access: yesSAGE Open Medicine, 2021
Marijuana use is on the rise in the United States. By the end of 2019, 33 states have legalized marijuana use and marijuana byproduct use for medical purposes. However, marijuana use does not come without side effects.
Asim Kichloo   +9 more
doaj   +1 more source

Responsive stimulation of the thalamus for idiopathic generalized epilepsy: Results of the randomized controlled NAUTILUS trial through 18 months

open access: yesEpilepsia, EarlyView.
Abstract Objective This study was undertaken to evaluate the safety and effectiveness of responsive thalamic stimulation as adjunctive therapy for drug‐resistant idiopathic generalized epilepsy (IGE) with generalized tonic–clonic seizures (GTCSs). Methods NAUTILUS is a prospective, multicenter, single‐blind, randomized sham‐controlled pivotal trial ...
Utku Uysal   +47 more
wiley   +1 more source

Medical Marijuana Laws, Traffic Fatalities, and Alcohol Consumption [PDF]

open access: yes
To date, 16 states have passed medical marijuana laws, yet very little is known about their effects. Using state-level data, we examine the relationship between medical marijuana laws and a variety of outcomes.
Anderson, D. Mark, Rees, Daniel I.
core  

Cannabidiol reduces atypical absence seizures and epileptic spasms in a Gabrb3+/D120N mouse model of Lennox–Gastaut syndrome

open access: yesEpilepsia Open, EarlyView.
Abstract Objective Lennox–Gastaut syndrome (LGS) is a drug‐resistant developmental and epileptic encephalopathy (DEE). Preclinical drug development for LGS is constrained by a lack of syndrome‐relevant animal models. We aimed to evaluate a Gabrb3+/D120N knock‐in (KI) mouse model of LGS by quantifying atypical absence seizures and epileptic spasms and ...
Thomas Harman   +5 more
wiley   +1 more source

Clinical Considerations for Cannabis Use and Cardiovascular Health

open access: yesMedical Cannabis and Cannabinoids, 2022
Ruba Sajdeya   +4 more
doaj   +1 more source

Weighing the Benefits and Risks of Medical Marijuana Use: A Brief Review

open access: yesPharmacy, 2018
Despite federal prohibition of medical marijuana possession, sale, and use, marijuana use continues to escalate as state legalization persists and expands.
Allison Karst
doaj   +1 more source

High on Life? Medical Marijuana Laws and Suicide [PDF]

open access: yes
Using state-level data for the period 1990 through 2007, we estimate the effect of legalizing medical marijuana on suicide rates. Our results suggest that the passage of a medical marijuana law is associated with an almost 5 percent reduction in the ...
Anderson, D. Mark   +2 more
core  

Smartphone videos for infantile epileptic spasms triaging and assessment (VISTA study): Impact of education and standardized clinical history on diagnostic accuracy

open access: yesEpilepsia Open, EarlyView.
Abstract Objective Diagnostic and treatment delays in infantile epileptic spasms syndrome (IESS) increase the risk of poor neurodevelopmental outcomes. Early clinical recognition of IESS is essential, especially in regions lacking expedited access to electroencephalograms (EEG).
Christine L. Shrock   +11 more
wiley   +1 more source

Perinatal Cannabis Exposures and Autism Spectrum Disorders

open access: yesMedical Cannabis and Cannabinoids, 2021
Ruba Sajdeya   +2 more
doaj   +1 more source

The Oregon Medical Marijuana Program

open access: yes, 2015
This archived document is maintained by the Oregon State Library as part of the Oregon Documents Depository Program. It is for informational purposes and may not be suitable for legal purposes.Title from cover."OHA 9323 (rev.

core  

Home - About - Disclaimer - Privacy